275
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

High utilization of inpatient detoxification: predictors among US veterans

, MD, MPH, , MD, MPH, , DO, MPH, , MD, , MD & , MD
Pages 279-286 | Received 31 Mar 2015, Accepted 28 Aug 2015, Published online: 30 Oct 2015

References

  • Vest JR, Gamm LD, Oxford VA, Gonzalez MI, Slawson KM. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci 2010;5:88.
  • Allaudeen N, Schnipper JL, Orav EJ, Wachter RM, Vidyarthi AR. Inability of providers to predict unplanned readmissions. J Gen Intern Med 2011;26:771–776.
  • Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, Kripalani S. Risk prediction models for hospital readmission. JAMA 2011:306:1688–1698.
  • Rabinowitz J, Mark M, Pooper M, Slyuzber M, Munitz H. Predicting revolving door patients in a 9 year national sample. Soc Psychiatry Psychiatry Epidemiol 1995;30:65–72.
  • Leppin AL, Gionfriddo MR, Kessler M, Brito JP, Mair FS, Gallacher K, Wang Z, et al. Preventing 30-day hospital readmission: a systematic review and meta-analysis of randomized trials. JAMA Intern Med 2014;174:1095–1107.
  • Gaines BN, Brown C, Lux LJ, Ashok M, Coker-Schweinner E, Hoffman V, Sheitman B, et al. Management strategies to reduce psychiatric readmissions. Technical Brief No. 21. (Prepared by the RTI-UNC Evidence-based Practice Center under Contract No. 290-2012-0008-I.) AHRQ Publication No. 15-EHC018-EF. Rockville, MD: Agency for Healthcare Research and Quality (www.effectivehealthcare.ahrq.gov/reports/final.cfm).
  • Calvillo-King L, Arnold D, Eubank KJ, Lo M, Yunyongying P, Steiglitz H, Halm EA. Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med 2012;28:269–282.
  • Lichtman JH, Leifheith-Limson EC, Jones SB, Watanabe E, Bernheim SM, Phippis MS, Bhat KR, et al. Predictors of readmission after stroke: a systematic review. Stroke 2010;41:2525–2533.
  • Booth BM, Yates WR, Petty F, Brown K. Patient factors predicting early alcohol-related readmissions for alcoholics: role of alcoholism severity and psychiatric co-morbidity. J Stud Alcohol 1991;52:37–43.
  • Hendryx MS, Russo JE, Stegner B, Dyck DG, Ries RK, Roy-Byrne P. Predicting rehospitalization and outpatient services from administration and clinical databases. J Behav Health Serv Res 2003;30:342–351.
  • Mark TL, Vandivort-Warren R, Montejano LB. Factors affecting detoxification readmission: analysis of public sector data from three states. J Subst Abuse Treat 2006;31:439–445.
  • Amodeo M, Lundgren L, Chassler D, Witas J. High-frequency users of detoxification: who are they? Subst Use Misuse 2008;43:839–843.
  • Carrier E McNeely J, Lobach I, Tay S, Gourevitch MN, Raven MC. Factors associated with frequent utilization of crisis substance use detoxification services. J Addict Dis 2011;30:116–122.
  • Mark T, Tomic KS, Kowlessar N, Chu BC, Vandivort-Warren R, Smith S. Hospital readmission among Medicaid patients with an index hospitalization for mental and/or substance use disorder. J Behav Health Serv Res 2013;40:207–221.
  • Garnick DW, Lee MT, Horgan CM, Acevedo A, and the Washington Circle Public Sector Workgroup. Adapting Washington Circle Performance Measures for public sector substance abuse treatment systems. J Subst Abuse Treat 2009;36:265–277.
  • Lee MT, Horgan CM, Garnick DW, Acevedo A, Panas L, Ritter GA, Dunigan R, et al. A performance measure for continuity of care after detoxification: relationship with outcomes. J Subst Abuse Treat 2014;47:130–139.
  • Pines JM. How frequent emergency department use by US veterans can inform good public policy. Ann Emerg Med 2013;62:160–161.
  • Humphreys K, McLellan AT. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 2011;106:2058–2066.
  • Burke RE, Donze J, Schnipper JL. Contribution of psychiatric illness and substance abuse to 30-day readmission risk. J Hosp Med 2013:8:450–455.
  • Raven MC, Carrier EF, Lee J, Billings JC, Marr M, Gourevitch MN. Substance use treatment barriers for patients with frequent hospital admissions. J Subst Abuse Treat 2010;38:22–30.
  • Alafaireet P, Houghton H, Petroski G, Gong Y, Savage GT. Toward determining the structure of psychiatric visit non adherence. J Ambulatory Care Manage 2010;33:108–116.
  • Sands LP, Daggy JK, Lawley M, Willis D, Thayer D, et al. Using no show modeling to improve clinical performance. School of Nursing Faculty Publications. Paper 1. Available at: http://dx.doi.1177/1460458210380521 [last accessed 18 December 2014].
  • Open Epi (Computer program). Version 3.04.04, Atlanta, GA: Emory University; 2015.
  • SAS (Computer program). Version 9.3. Cary, NC: SAS Institute; 2010
  • Webb S, Yaguez L, Langdon PE. Factors associated with multiple re-admission to a psychiatric hospital. J Ment Health 2007;16:647–661.
  • Molfenter T. Reducing appointment no shows: going from theory to practice. Subst Use Misuse 2013;48:743–749.
  • Kramer L. Mental Health Case Study – NIATx. Available at: www.niatx.net/PDF/PIPractice/MentalHealth/MHB_COMHAR.pdf [last accessed 8 January 2015].
  • Angarita GA, Reif S, Pirard S, Lee S, Sharon E, Gastfriend DR. No show for treatment in substance abuse patients with comorbid symptomatology: validity of results from a controlled trial of the ASAM placement criteria. J Addict Med 2007;2:79–87.
  • Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans’ Health Administration. Psychiatr Serv 2010;61:392–398.
  • Iheanacho T, Issa M, Marienfeld C, Rosenheck R. Use of naltrexone for alcohol use disorders in the Veteran’s Health Administration: a national study. Drug Alcohol Depend 2013;132:122–126.
  • Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav 2011;36:584–589.
  • Tomasson K, Vaglum P. The role of psychiatric comorbidity in the prediction of readmission for detoxification. Compr Psychiatry 1998;39:129–136.
  • Millery M, Kleinman BP, Polissar NL, Millman RB, Scimeca M. Detoxification as a gateway to long-term treatment: assessing two interventions. J Subst Abuse Treat 2002;23:183–190.
  • Callaghan RC, Cunningham JA. Intravenous and non-intravenous cocaine abusers admitted to inpatient detoxification treatment: a 3 year medical chart review of patient characteristics and predictors of treatment readmission. Drug Alcohol Depend 2002;323–328.
  • Carroll CP, Triplett PT, Mondimore FM. The intensive treatment unit: a brief inpatient detoxification facility demonstrating good postdetoxification treatment entry. J Subst Abuse Treat 2009;111–119.
  • Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, three- and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse 2001;27:19–44.
  • McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness. JAMA 2000;284:1689–1695.
  • Doran KM, Raven, MC, Rosenheck RA. What drives frequent emergency department use in an integrated health system? National data from the Veterans Health Administration. Ann Emerg Med 2013;62:151–159.
  • Schellekens AFA, deJong CAJ, Buitelaar JK, Verkes RJ. Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. Euro Psychiatry 2015;30:128–136.
  • Campbell BK, Bryant K, DiCenzo J, et al. Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abuse Treat 2010;38(Suppl. 1):S87–96.
  • Juven-Wetzler A, Bar-Ziv D, Cwikel-Hamzany S, Abudy A, Peri N, Zohar J. A pilot study of the continuation of care model in revolving door patients. Euro Psychiatry 2012;27:229–233.
  • Ford LK, Zarate P. Closing the gaps: the impact of inpatient detoxification and continuity of care on client outcomes. J Psychoactive Drugs 2010;(SARC Suppl. 6):303–314.
  • Dieterich M, Irving CB, Park B, Marshall M. Intensive case management for severe mental illness. Cochrane Database of Systematic Reviews 2010. Issue 10. Art. No. CD007906. DOI:10.1002/14651858. CD007906. Pub2.
  • Buck JA. The looming expansion and transformation of public substance abuse treatment under the affordable care act. Health Aff (Millwood) 2011;8:1402–1410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.